Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery
Recently the high transfection potential of the cationic polymer polyethylenimine (PEI) was described (Boussif O et al. Proc Natl Acad Sci USA 1995; 92: 7297-7301). To combine the promising DNA delivering activity of PEI with the concept of receptor-mediated gene delivery, cell-binding ligands (tran...
Gespeichert in:
Veröffentlicht in: | Gene therapy 1997-05, Vol.4 (5), p.409-418 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 418 |
---|---|
container_issue | 5 |
container_start_page | 409 |
container_title | Gene therapy |
container_volume | 4 |
creator | KIRCHEIS, R KICHLER, A WALLNER, G KURSA, M OGRIS, M FELZMANN, T BUCHBERGER, M WAGNER, E |
description | Recently the high transfection potential of the cationic polymer polyethylenimine (PEI) was described (Boussif O et al. Proc Natl Acad Sci USA 1995; 92: 7297-7301). To combine the promising DNA delivering activity of PEI with the concept of receptor-mediated gene delivery, cell-binding ligands (transferrin or antiCD3 antibody) were incorporated by covalent linkage to PEI. DNA complexes of PEI or ligand-PEI conjugates were tested for transfection of cultured neuroblastoma Neuro 2A cells, melanoma B16 or H225 cells, erythroid leukemic K562 cells and T cell leukemia Jurkat E6.1 cells. Depending on the cell line, incorporation of the cell-binding ligand resulted in an up to 1000-fold increased transfection efficiency. This activity depends on ligand-receptor interaction and was observed also at low PEI cation:DNA anion ratios where ligand-free PEI lacks efficiency. Depending on the cell-binding ligand, specific targeting (CD3 antibody, Jurkat cells) can be achieved. Gene transfer can be augmented by the addition of an endosome-destabilizing influenza peptide, but is not dependent on the presence of additional endosomolytic agents. Application of transferrin-PEI for the production of murine interleukin-2 in B16 cells resulted in exceptionally high secretion rates of 19 micrograms IL-2 protein per 10(6) cells per 24 h. |
doi_str_mv | 10.1038/sj.gt.3300418 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79236427</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16033592</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-5f58c799b28697e2fcc0504078622ba61e185d5aaab5a48577825ede89418d053</originalsourceid><addsrcrecordid>eNqF0Utr3DAQAGARWpLNJsccA4aG3LzR-3EsS_qAQC7tWcj22NGitTaSHdh_Hy0xOfTSkxjNxzAPhG4I3hDM9EPebYZpwxjGnOgztCJcyVpwSb-gFTbS1IpQfYEuc97hYpSm5-jcUMUVUSv0vI3zIfhxqGJftRBC3fixO8XBD27scjXF6hDDEaaXY4DR7_0IVR9TNbk0wARdNUD56SD4N0jHK_S1dyHD9fKu0d8fj3-2v-qn55-_t9-f6pZrMtWiF7pVxjRUS6OA9m2LBeZYaUlp4yQBokUnnHONcFwLVdoW0IE2ZcgOC7ZG9x91Dym-zpAnu_f51L8bIc7ZKkOZ5FT9FxKJGRNFr9G3f-AuzmksQ1gqednnadtF1R-qTTHnBL09JL936WgJtidh884Ok13uUfztUnVu9tB96uUAJX-35F1uXeiTG1ufPxmVGhNm2Dt9RpH2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2644621038</pqid></control><display><type>article</type><title>Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>KIRCHEIS, R ; KICHLER, A ; WALLNER, G ; KURSA, M ; OGRIS, M ; FELZMANN, T ; BUCHBERGER, M ; WAGNER, E</creator><creatorcontrib>KIRCHEIS, R ; KICHLER, A ; WALLNER, G ; KURSA, M ; OGRIS, M ; FELZMANN, T ; BUCHBERGER, M ; WAGNER, E</creatorcontrib><description>Recently the high transfection potential of the cationic polymer polyethylenimine (PEI) was described (Boussif O et al. Proc Natl Acad Sci USA 1995; 92: 7297-7301). To combine the promising DNA delivering activity of PEI with the concept of receptor-mediated gene delivery, cell-binding ligands (transferrin or antiCD3 antibody) were incorporated by covalent linkage to PEI. DNA complexes of PEI or ligand-PEI conjugates were tested for transfection of cultured neuroblastoma Neuro 2A cells, melanoma B16 or H225 cells, erythroid leukemic K562 cells and T cell leukemia Jurkat E6.1 cells. Depending on the cell line, incorporation of the cell-binding ligand resulted in an up to 1000-fold increased transfection efficiency. This activity depends on ligand-receptor interaction and was observed also at low PEI cation:DNA anion ratios where ligand-free PEI lacks efficiency. Depending on the cell-binding ligand, specific targeting (CD3 antibody, Jurkat cells) can be achieved. Gene transfer can be augmented by the addition of an endosome-destabilizing influenza peptide, but is not dependent on the presence of additional endosomolytic agents. Application of transferrin-PEI for the production of murine interleukin-2 in B16 cells resulted in exceptionally high secretion rates of 19 micrograms IL-2 protein per 10(6) cells per 24 h.</description><identifier>ISSN: 0969-7128</identifier><identifier>EISSN: 1476-5462</identifier><identifier>DOI: 10.1038/sj.gt.3300418</identifier><identifier>PMID: 9274717</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Animals ; Antibodies ; B-Lymphocytes - secretion ; Biological and medical sciences ; Biotechnology ; CD3 antigen ; CD3 Complex - immunology ; Cell Line ; Deoxyribonucleic acid ; DNA ; Endosomes ; Fundamental and applied biological sciences. Psychology ; Gene Targeting ; Gene therapy ; Gene transfer ; Gene Transfer Techniques ; Health. Pharmaceutical industry ; Humans ; Industrial applications and implications. Economical aspects ; Influenza ; Interleukin 2 ; Interleukin-2 - secretion ; Jurkat Cells ; Leukemia ; Ligands ; Lymphocytes T ; Melanoma ; Mice ; Neuroblastoma ; Polyethyleneimine ; Polymers ; Protein Binding ; Receptors, Transferrin - metabolism ; Transfection ; Transferrin ; Transferrin - metabolism ; Tumor Cells, Cultured</subject><ispartof>Gene therapy, 1997-05, Vol.4 (5), p.409-418</ispartof><rights>1997 INIST-CNRS</rights><rights>Macmillan Publishers Limited 1997.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-5f58c799b28697e2fcc0504078622ba61e185d5aaab5a48577825ede89418d053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,27933,27934</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2680139$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9274717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KIRCHEIS, R</creatorcontrib><creatorcontrib>KICHLER, A</creatorcontrib><creatorcontrib>WALLNER, G</creatorcontrib><creatorcontrib>KURSA, M</creatorcontrib><creatorcontrib>OGRIS, M</creatorcontrib><creatorcontrib>FELZMANN, T</creatorcontrib><creatorcontrib>BUCHBERGER, M</creatorcontrib><creatorcontrib>WAGNER, E</creatorcontrib><title>Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery</title><title>Gene therapy</title><addtitle>Gene Ther</addtitle><description>Recently the high transfection potential of the cationic polymer polyethylenimine (PEI) was described (Boussif O et al. Proc Natl Acad Sci USA 1995; 92: 7297-7301). To combine the promising DNA delivering activity of PEI with the concept of receptor-mediated gene delivery, cell-binding ligands (transferrin or antiCD3 antibody) were incorporated by covalent linkage to PEI. DNA complexes of PEI or ligand-PEI conjugates were tested for transfection of cultured neuroblastoma Neuro 2A cells, melanoma B16 or H225 cells, erythroid leukemic K562 cells and T cell leukemia Jurkat E6.1 cells. Depending on the cell line, incorporation of the cell-binding ligand resulted in an up to 1000-fold increased transfection efficiency. This activity depends on ligand-receptor interaction and was observed also at low PEI cation:DNA anion ratios where ligand-free PEI lacks efficiency. Depending on the cell-binding ligand, specific targeting (CD3 antibody, Jurkat cells) can be achieved. Gene transfer can be augmented by the addition of an endosome-destabilizing influenza peptide, but is not dependent on the presence of additional endosomolytic agents. Application of transferrin-PEI for the production of murine interleukin-2 in B16 cells resulted in exceptionally high secretion rates of 19 micrograms IL-2 protein per 10(6) cells per 24 h.</description><subject>Animals</subject><subject>Antibodies</subject><subject>B-Lymphocytes - secretion</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>CD3 antigen</subject><subject>CD3 Complex - immunology</subject><subject>Cell Line</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Endosomes</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Targeting</subject><subject>Gene therapy</subject><subject>Gene transfer</subject><subject>Gene Transfer Techniques</subject><subject>Health. Pharmaceutical industry</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>Influenza</subject><subject>Interleukin 2</subject><subject>Interleukin-2 - secretion</subject><subject>Jurkat Cells</subject><subject>Leukemia</subject><subject>Ligands</subject><subject>Lymphocytes T</subject><subject>Melanoma</subject><subject>Mice</subject><subject>Neuroblastoma</subject><subject>Polyethyleneimine</subject><subject>Polymers</subject><subject>Protein Binding</subject><subject>Receptors, Transferrin - metabolism</subject><subject>Transfection</subject><subject>Transferrin</subject><subject>Transferrin - metabolism</subject><subject>Tumor Cells, Cultured</subject><issn>0969-7128</issn><issn>1476-5462</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0Utr3DAQAGARWpLNJsccA4aG3LzR-3EsS_qAQC7tWcj22NGitTaSHdh_Hy0xOfTSkxjNxzAPhG4I3hDM9EPebYZpwxjGnOgztCJcyVpwSb-gFTbS1IpQfYEuc97hYpSm5-jcUMUVUSv0vI3zIfhxqGJftRBC3fixO8XBD27scjXF6hDDEaaXY4DR7_0IVR9TNbk0wARdNUD56SD4N0jHK_S1dyHD9fKu0d8fj3-2v-qn55-_t9-f6pZrMtWiF7pVxjRUS6OA9m2LBeZYaUlp4yQBokUnnHONcFwLVdoW0IE2ZcgOC7ZG9x91Dym-zpAnu_f51L8bIc7ZKkOZ5FT9FxKJGRNFr9G3f-AuzmksQ1gqednnadtF1R-qTTHnBL09JL936WgJtidh884Ok13uUfztUnVu9tB96uUAJX-35F1uXeiTG1ufPxmVGhNm2Dt9RpH2</recordid><startdate>19970501</startdate><enddate>19970501</enddate><creator>KIRCHEIS, R</creator><creator>KICHLER, A</creator><creator>WALLNER, G</creator><creator>KURSA, M</creator><creator>OGRIS, M</creator><creator>FELZMANN, T</creator><creator>BUCHBERGER, M</creator><creator>WAGNER, E</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>19970501</creationdate><title>Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery</title><author>KIRCHEIS, R ; KICHLER, A ; WALLNER, G ; KURSA, M ; OGRIS, M ; FELZMANN, T ; BUCHBERGER, M ; WAGNER, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-5f58c799b28697e2fcc0504078622ba61e185d5aaab5a48577825ede89418d053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Antibodies</topic><topic>B-Lymphocytes - secretion</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>CD3 antigen</topic><topic>CD3 Complex - immunology</topic><topic>Cell Line</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Endosomes</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Targeting</topic><topic>Gene therapy</topic><topic>Gene transfer</topic><topic>Gene Transfer Techniques</topic><topic>Health. Pharmaceutical industry</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>Influenza</topic><topic>Interleukin 2</topic><topic>Interleukin-2 - secretion</topic><topic>Jurkat Cells</topic><topic>Leukemia</topic><topic>Ligands</topic><topic>Lymphocytes T</topic><topic>Melanoma</topic><topic>Mice</topic><topic>Neuroblastoma</topic><topic>Polyethyleneimine</topic><topic>Polymers</topic><topic>Protein Binding</topic><topic>Receptors, Transferrin - metabolism</topic><topic>Transfection</topic><topic>Transferrin</topic><topic>Transferrin - metabolism</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KIRCHEIS, R</creatorcontrib><creatorcontrib>KICHLER, A</creatorcontrib><creatorcontrib>WALLNER, G</creatorcontrib><creatorcontrib>KURSA, M</creatorcontrib><creatorcontrib>OGRIS, M</creatorcontrib><creatorcontrib>FELZMANN, T</creatorcontrib><creatorcontrib>BUCHBERGER, M</creatorcontrib><creatorcontrib>WAGNER, E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KIRCHEIS, R</au><au>KICHLER, A</au><au>WALLNER, G</au><au>KURSA, M</au><au>OGRIS, M</au><au>FELZMANN, T</au><au>BUCHBERGER, M</au><au>WAGNER, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery</atitle><jtitle>Gene therapy</jtitle><addtitle>Gene Ther</addtitle><date>1997-05-01</date><risdate>1997</risdate><volume>4</volume><issue>5</issue><spage>409</spage><epage>418</epage><pages>409-418</pages><issn>0969-7128</issn><eissn>1476-5462</eissn><abstract>Recently the high transfection potential of the cationic polymer polyethylenimine (PEI) was described (Boussif O et al. Proc Natl Acad Sci USA 1995; 92: 7297-7301). To combine the promising DNA delivering activity of PEI with the concept of receptor-mediated gene delivery, cell-binding ligands (transferrin or antiCD3 antibody) were incorporated by covalent linkage to PEI. DNA complexes of PEI or ligand-PEI conjugates were tested for transfection of cultured neuroblastoma Neuro 2A cells, melanoma B16 or H225 cells, erythroid leukemic K562 cells and T cell leukemia Jurkat E6.1 cells. Depending on the cell line, incorporation of the cell-binding ligand resulted in an up to 1000-fold increased transfection efficiency. This activity depends on ligand-receptor interaction and was observed also at low PEI cation:DNA anion ratios where ligand-free PEI lacks efficiency. Depending on the cell-binding ligand, specific targeting (CD3 antibody, Jurkat cells) can be achieved. Gene transfer can be augmented by the addition of an endosome-destabilizing influenza peptide, but is not dependent on the presence of additional endosomolytic agents. Application of transferrin-PEI for the production of murine interleukin-2 in B16 cells resulted in exceptionally high secretion rates of 19 micrograms IL-2 protein per 10(6) cells per 24 h.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>9274717</pmid><doi>10.1038/sj.gt.3300418</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0969-7128 |
ispartof | Gene therapy, 1997-05, Vol.4 (5), p.409-418 |
issn | 0969-7128 1476-5462 |
language | eng |
recordid | cdi_proquest_miscellaneous_79236427 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Animals Antibodies B-Lymphocytes - secretion Biological and medical sciences Biotechnology CD3 antigen CD3 Complex - immunology Cell Line Deoxyribonucleic acid DNA Endosomes Fundamental and applied biological sciences. Psychology Gene Targeting Gene therapy Gene transfer Gene Transfer Techniques Health. Pharmaceutical industry Humans Industrial applications and implications. Economical aspects Influenza Interleukin 2 Interleukin-2 - secretion Jurkat Cells Leukemia Ligands Lymphocytes T Melanoma Mice Neuroblastoma Polyethyleneimine Polymers Protein Binding Receptors, Transferrin - metabolism Transfection Transferrin Transferrin - metabolism Tumor Cells, Cultured |
title | Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T06%3A35%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Coupling%20of%20cell-binding%20ligands%20to%20polyethylenimine%20for%20targeted%20gene%20delivery&rft.jtitle=Gene%20therapy&rft.au=KIRCHEIS,%20R&rft.date=1997-05-01&rft.volume=4&rft.issue=5&rft.spage=409&rft.epage=418&rft.pages=409-418&rft.issn=0969-7128&rft.eissn=1476-5462&rft_id=info:doi/10.1038/sj.gt.3300418&rft_dat=%3Cproquest_cross%3E16033592%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2644621038&rft_id=info:pmid/9274717&rfr_iscdi=true |